High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages 1405-1410

  Meijer, Hanneke J M ^a   Van Lin, Emile N ^a   Debats, Oscar A ^a   Witjes, J Alfred ^a   Span, Paul N ^a   Kaanders, Johannes H A M ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lymph node metastases; Lymphotrophic superparamagnetic nanoparticles; Magnetic resonance imaging; Prostate cancer; Salvage radiotherapy

Indexed keywords

CLINICAL TARGET VOLUMES; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH NODE REGION; LYMPHOTROPHIC SUPERPARAMAGNETIC NANOPARTICLES; PELVIC IRRADIATION; POSITIVE LYMPH NODES; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RADIATION THERAPY ONCOLOGY GROUPS; RADICAL PROSTATECTOMY; SALVAGE RADIOTHERAPY;

DISEASES; IRRADIATION; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOTHERAPY; SUPERPARAMAGNETISM; UROLOGY;

BODY FLUIDS;

PROSTATE SPECIFIC ANTIGEN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; HUMAN; IRRADIATION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIC IRRADIATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE RADIOTHERAPY; SALVAGE THERAPY;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DEXTRANS; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SALVAGE THERAPY;

EID: 84857920625     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.054     Document Type: Article

References (30)

1. F.J. Bianco Jr., P.T. Scardino, and J.A. Eastham Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 5 Suppl 2005 83 94
2. R.G. Cremers, E.N. van Lin, and W.L. Gerrits Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy Radiother Oncol 97 2010 467 473
3. S.B. Hayes, and A. Pollack Parameters for treatment decisions for salvage radiation therapy J Clin Oncol 23 2005 8204 8211
4. A.J. Stephenson, S.F. Sharia, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
5. A.K. Leventis, S.F. Shariat, and M.W. Kattan Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy J Clin Oncol 19 2001 1030 1039
6. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
7. M.T. Spiotto, S.L. Hancock, and C.R. King Radiotherapy after prostatectomy: Improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients Int J Radiat Oncol Biol Phys 69 2007 54 61
8. I. van der Ploeg, H.S. Oldenburg, and E.J. Rutge Lymphatic drainage patterns from the treated breast Ann Surg Oncol 17 2010 1069 1075
9. P. Schrenk, C. Tausch, and W. Wayand Lymphatic mapping in patients with primary or recurrent breast cancer following previous axillary surgery Eur J Surg Oncol 34 2008 851 856
10. S.H. Estourgie, R.A. Valdes Olmos, and O.E. Nieweg Excision biopsy of breast lesions changes the pattern of lymphatic drainage Br J Surg 94 2007 1088 1091
11. A.M. Hovels, R.A. Heesakkers, and E.M. Adang The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: A meta-analysis Clin Radiol 63 2008 387 395
12. A. Briganti, M.L. Blute, and J.H. Eastham Pelvic lymph node dissection in prostate cancer Eur Urol 55 2009 1251 1265
13. R.A. Heesakkers, A.M. Hovels, and G.J. Jager MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: A prospective multicohort study Lancet Oncol 9 2008 850 856
14. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499
15. C.A. Lawton, J. Michalski, and I. El-Naqa RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383 387
16. J.O. Barentsz, J.J. Futterer, and S. Takahashi Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients Eur J Radiol 63 2007 369 372
17. H.A. Shih, M. Harisinghani, and A.L. Zietman Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy Int J Radiat Oncol Biol Phys 63 2005 1262 1269
18. R. Martinez-Monge, P.S. Fernandes, and N. Gupta Cross-sectional nodal atlas: A tool for the definition of clinical target volumes in three-dimensional radiation therapy planning Radiology 211 1999 815 828
19. R.W. Ross, A.L. Zietman, and W. Xie Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy Clin Imaging 33 2009 301 305
20. G. Giovacchini, M. Picchio, and E. Coradeschi Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 2010 301 309
21. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: Results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429
22. D. Moghanaki, B. Koontz, and J. Karlin Improved biochemical complete response (BCR) and biochemical relapse-free survival (RFS) with whole pelvis (WPRT) vs. prostate bed (PBRT) radiotherapy in patients undergoing salvage treatment following prostatectomy (Abstr.) Int J Radiat Oncol Biol Phys 78 3 Suppl. 1 2010 S30 S31
23. L. Vermeeren, W. Meinhardt, and H.G. van der Poel Lymphatic drainage from the treated versus untreated prostate: Feasibility of sentinel node biopsy in recurrent cancer Eur J Nucl Med Mol Imaging 37 2010 2021 2026
24. H. Hricak, P.L. Choyke, and S.C. Eberhardt Imaging prostate cancer: A multidisciplinary perspective Radiology 243 2007 28 53
25. P. Castellucci, C. Fuccio, and D. Rubello Is there a role for (11)C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? Eur J Nucl Med Mol Imaging 38 2011 55 63
26. U. Ganswindt, D. Schilling, and A.C. Muller Distribution of prostate sentinel nodes: A SPECT-derived anatomic atlas Int J Radiat Oncol Biol Phys 79 2011 1364 1372
27. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
28. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
29. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
30. H.J. Meijer, O.A. Debats, and M. Kunze-Busch Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer Int J Radiat Oncol Biol Phys 2010 Sept 23. [Epub ahead of print]